There are 101 resources available
The role of surgery in newly-diagnosed and recurrent ovarian cancer in the era of targeted therapies
Presenter: Sven Mahner
Session: Ovarian cancer management in the PARP inhibitor era
Resources:
Slides
Webcast
How to make the best of PARP inhibitor therapy: When, who and how?
Presenter: Robert Coleman
Session: Ovarian cancer management in the PARP inhibitor era
Resources:
Slides
Webcast
How to treat ovarian cancer post and beyond PARP inhibitors?
Presenter: Stephanie Lheureux
Session: Ovarian cancer management in the PARP inhibitor era
Resources:
Slides
Webcast
Live Q&A
Presenter: Susana Banerjee
Session: Ovarian cancer management in the PARP inhibitor era
Resources:
Webcast
Introduction and first vote
Presenter: Mansoor Raza Mirza
Session: Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Resources:
Slides
Webcast
Pro
Presenter: Nicoletta Colombo
Session: Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Resources:
Slides
Webcast
Con
Presenter: Ana Oaknin
Session: Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Domenica Lorusso
Session: Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Resources:
Slides
Webcast
Introduction
Presenter: Domenica Lorusso
Session: Keynote lecture: Changes in practice and research breakthroughs in the treatment of gynaecological cancers
Resources:
Slides
Webcast
<b>Changes in practice and research breakthroughs in the treatment of gynaecological cancers</b>
Presenter: Eric Pujade-Lauraine
Session: Keynote lecture: Changes in practice and research breakthroughs in the treatment of gynaecological cancers
Resources:
Slides
Webcast